Population pharmacokinetic and dose–response models of nepadutant, a selective antagonist of the NK<sub>2</sub> receptors, in infants with colic
Population pharmacokinetic and dose-response models were successfully developed characterizing the available nepadutant pharmacokinetics and duration of crying and fussing data in infants.
Authors
- Siv Jönsson (ORCID: https://orcid.org/0000-0001-8240-0865)
- E. Niclas Jonsson (ORCID: https://orcid.org/0000-0002-2615-0280)
- Alessia Tagliavini
- Andrea Pellacani
- Elisa Borella
- Chiara Piana
- Sibylle Koletzko (ORCID: https://orcid.org/0000-0003-2374-8778)
- Salim Bouchène (ORCID: https://orcid.org/0000-0003-1078-6708)
- Mats O. Karlsson (ORCID: https://orcid.org/0000-0003-1258-8297)
- Katharina Werkstetter (ORCID: https://orcid.org/0000-0001-9776-8275)
- Angela Capriati
- Paolo Mazzei
Institutions
- Menarini Group (Italy) (IT)
- University of Warmia and Mazury in Olsztyn (PL)
- Ludwig-Maximilians-Universität München (DE)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1111/bcp.16230
- Primary Topic
- Infant Health and Development
- Type
- article
- Field-Weighted Citation Impact
- 0.00